Introduction
============

Non-communicable polygenic diseases such as cancers, neurodegeneration, cardiovascular, and metabolic disorders have become the most prevalent type worldwide and account for the majority of death events in developed and transition economy countries ([@B20]; [@B6]). Initiation and development of complex diseases is governed by both, genetic and environmental factors ([@B45]). Genetic predisposition to complex diseases is not a result of a single mutation, but they require synergic effect of variations in many genes. These variants can be more frequent and/or rare in a population giving rise to "common variant" and "rare variant" hypotheses ([@B43]; [@B47]). Currently, one of the primary tasks of genome medicine is to identify panels of complex disease-predisposing genetic markers for use in disease prognostics, diagnostics as well as drug development ([@B1]).

The most applied method for searching multiple genetic variants is a genome-wide association study (GWAS). During last decades, thousands GWAS have identified numerous single nucleotide polymorphisms (SNPs) associated with different complex diseases such as cancers, schizophrenia and diabetes, Alzheimer's and Parkinson's diseases ([@B17]; [@B15]; [@B53]; [@B8]). However, associations reported in one population often do not replicate when studied in another population and, moreover, sometimes they are being reported as neutral or even protective ones ([@B12]; [@B48]; [@B33]).

The explanation for this fact is that most GWAS employ a case-control design in selected populations, mainly of European, and in lesser extent from African and Chinese origin while other populations largely remain understudied. This issue has gained significant attention during recent years and number of papers has been published which evaluate how risk allele frequencies at known disease loci vary across populations and how this causes biases in population risk score estimation ([@B24]; [@B1]; [@B26]). Moreover, it has been lately shown that assessment of population-level distribution of disease risk alleles can contribute to public healthcare planning ([@B30]). However, most of this kind of studies either focus on limited population diversity or on a limited set of disease-SNP associations.

Moreover, the inclusion of genetically isolated populations will considerably enhance the understanding of complex trait-associated variants because of their reduced allele diversity ([@B28]).

In order to describe the entire landscape of population-level variation of diseases-associated SNPs across multiple populations and geographic regions, we used a bioinformatics pipeline based on self-organizing maps (SOM) machine learning. This method has been previously applied to different high-dimensional omics data such as transcriptomic, epigenomic, and proteomic data ([@B10]; [@B22], [@B21]; [@B3]). Its strong visualization capabilities and options for downstream bioinformatics analysis motivated us to apply SOM machine learning to genomic SNP data to study disease-associated risk profiles. We have investigated the distribution of about 44,000 disease-associated SNPs across 52 populations of different ancestry and geographical origin; among them the so-far understudied population of Armenians. Historically inhabiting the region of the South Caucasus, Armenian population was reproductively isolated since the Bronze Age ([@B19]), which makes them an interesting example for studying local specifics of the interaction of distribution of genetic risks for complex diseases with actual disease prevalence on the population level.

Materials and Methods {#s1}
=====================

Data and Pre-processing
-----------------------

In the first step of analysis population-related SNP data were merged with disease-associated SNPs and preprocessed ([Figure 1](#F1){ref-type="fig"}). We considered the following data sets.

![Schematic overview of the SOM-portrayal method applied for analysis of population SNP data (see section "Materials and Methods"). SNP data of different populations around the world taken from the Human Genome Diversity Project (HDGP) and of a cohort of 99 Armenians were filtered for disease associated SNPs collected from four databases (see section "Materials and Methods"). Then, the data matrix (44,234 SNPs × 1039 individuals) was used to train a SOM which delivers a SNP portrait of each individual. It represents a colored image showing clusters of SNPs with increased minor allele frequency (MAF) as red 'spot-like' areas. They were then used for extracting population-specific associations with disease risks and biological functions by applying enrichment techniques. The SOM mining step also makes use of overview maps summarizing all spots observed on population averaged mean portraits which characterize the SNP landscape of individuals of a certain geographic region and of SNP profiles showing the allele score across all individuals and populations studied. For example, the red minor-allelic spot in the right-upper corner of the map (see dashed circle) is specific for Africans because it is observed in their portraits but not in the portrait of Europeans. Its profile shows high and low values of the allele score for individuals from these regions. Each of the spots delivers a list of SNPs and associated genes, which, in turn, are used to extract disease risks for populations showing these spots.](fgene-10-00394-g001){#F1}

### Population Data (HGDP and Armenians Data Set)

We used preprocessed genome-wide SNP data (Illumina 650Y arrays) taken from the Human Genome Diversity Project (HGDP^[1](#fn01){ref-type="fn"}^) after removal of atypical and duplicated samples. The data collect genotypes (650,0000 SNPs) from 940 individuals from 51 populations in 8 geographical regions (Africa, Europe, Middle East, South and Central Asia, East Asia, Oceania, and America) ([@B49]).

Single nucleotide polymorphisms data (Illumina Human Omniexpress microarray platform) of 99 Armenians (Eastern Armenian population) was taken from the recent publication by [@B19].

### Disease-Associated SNP Data

Lists of SNPs associated with diseases were collected from the following four databases: UniProt humsavar^[2](#fn02){ref-type="fn"}^, NCBI Clinvar^[3](#fn03){ref-type="fn"}^, GWASdb^[4](#fn04){ref-type="fn"}^, and DisGenNet^[5](#fn05){ref-type="fn"}^. The lists from all sources were then combined and the duplicated records were removed. The final list consisted of 321,955 disease-associated SNPs.

### SNP-Filtered Population Data

Disease-associated SNPs with minor allele frequency (MAF) \> 0.05 were selected from both data sets after removing missing genotypes using "vcftools." VCF genotype files were transformed into genotype matrix using "variant annotation" ([@B38]) and "snpstats" ([@B18]) R packages. Final dataset consisted of 44,234 disease-associated SNPs in 1039 samples that combined HGDP and Armenian populations.

### Allele Coding

For further data processing, SNP-genotypes were coded by the following integers: 0 -- homozygous major alleles genotype, 1 -- heterozygous alleles genotype, and 2 -- homozygous minor allele genotype. The full set of SNPs of each individual constitutes its SNP-portrait while the allele-coded values of each SNP over all individuals in the data set constitute its SNP-profile ([Figure 1](#F1){ref-type="fig"}).

### Disease Classification

We used Disease Ontology (DO, release 2018-07-05) based classification of diseases. The DO is structured into types of disease on different levels using a tree-model ([@B51]). For comparability of disease-SNP associations, we mapped DO-terms of level 4 and higher to level 3 of DO terms. For instance, diabetes mellitus (level 5) is assigned to carbohydrate metabolism disease (level 3) in further analysis ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}).

Generating SNP-Portraits Using Self-Organizing Maps
---------------------------------------------------

In the next step preprocessed and filtered HDGP SNP datasets were feature centralized and then clustered using SOM machine learning (see [@B57] for a detailed description of the method, and [Figure 1](#F1){ref-type="fig"} for a schematic representation). It translates the original data matrix consisting of the allele scores of *N* = 44,234 disease-associated SNPs collected from *M* = 1,039 individuals into a data matrix of reduced dimensionality of *K* = 3,025 so-called meta-SNP profiles. Hereby, the term 'profile' denotes the vector of allele score values across the individuals. The SOM training algorithm distributes the SNPs over the K micro-clusters of meta-SNPs by minimizing the Euclidian distance between the SNP-profiles as a similarity measure. This ensures that SNPs with similar profiles cluster together in the same or in closely located meta-SNPs. Each meta-SNP profile can be interpreted as the mean profile averaged over all SNP profiles referring to the respective meta-SNP cluster. The allele scores of the meta-SNPs of each individual are visualized by arranging them into a two-dimensional *M* = 55 × 55 grid and by using red to blue colors for a maximum to minimum allele score values in each of the grid images. These images 'portray' the genetic landscape of each individual studied. We used SOM implemented in "oposSOM" R package ([@B34]). All populations were labeled according to the geographical location while Armenians were considered as a separate group. Mean SNP-SOM portraits of populations from the same geographic regions were obtained by averaging the meta-SNP values of the respective individual SNP-portraits. A separate "zoom-in" SOM ([@B57]) was trained by considering only populations of the HDGP data set from the Middle East and Europe together with Armenians to better resolve details of their disease-associated genomes. Full data analysis results are available from Zenodo Open data platform ([@B37]).

Spot Clustering, Disease, and GO-Term Enrichment
------------------------------------------------

In the third step, we performed an analysis of the SOM-clustered data to assess disease-associated genetic risks across the populations. Our SOM implementation used a ternary code for coloring each meta-SNP giving rise to spot-like red and blue colored regions in the SNP-portraits due to the self-organizing properties of the SOM algorithm. Red and blue spots refer to minor and major allelic regions while green areas mark heterozygous alleles. We then used segmentation algorithms developed previously ([@B57]) to extract so-called spot-clusters of (red) minor-allelic regions. Each of these spot-clusters consists of 100 to 1000s of SNP-profiles. Enrichment of disease DO terms in the spot clusters was then estimated by Fisher's exact test. For each spot, the test assesses whether the number of SNPs associated with a given disease is larger than expected under the assumption of random distribution of SNPs among the spots. Enrichment analysis was also performed for gene-ontology (GO) terms "biological process" and "cellular component" using over-representation analysis as implemented in WebGestalt web-server ([@B55]) to assess the functional context of the genes containing the SNPs in a given spot.

Results
=======

SOM-Portrayal of Geographical Diversity of Disease-Associated SNPs
------------------------------------------------------------------

Human disease-related genetic diversity is shaped by demographic, biological, and environmental factors. Here we applied a SOM approach to gain new insights about population-level distributions of disease-predisposing alleles across geographic regions using whole genome SNP-scans of 1039 individual selected from 52 ethnicities in seven geographic regions and of Armenians considered separately. SOM was trained using ca. 44,000 disease-associated SNPs. We obtained a gallery of "SNP portraits" visualizing the genotypes of disease-associated SNPs for each individual studied ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}). Inspection of the portraits reveals high diversity of textures reflecting the allelic landscapes in terms of areas enriched for major homozygous, heterozygous and minor homozygous genotypes color-coded in blue, green, and red, respectively. On the other hand, sample portraits were mostly very similar for individuals originating from the same geographic region while the portraits of individuals from different regions progressively diverge with increasing geographic distance in most cases. For example, individuals from sub-Saharan Africa typically show a red "spot" in the right upper corner of their SOM-portraits which shifts toward the right lower corner for individuals from Middle East and Europe including Armenians. This shift reflects the fact that the latter three populations show on average similar collections of minor homozygous disease-associated SNPs which however differ markedly from those of Sub-Saharan Africans. The red spots in the mean portrait of individuals from Central and South Asia partly overlap with those of Europeans but it shows also new, ubiquitous spots referring to disease-risk associated SNPs not observed in Europeans. Also the mean portraits of East Asian, Native American, and Oceania populations reflect a combination of common and ubiquitous spots reflecting footprints of their population history. To visualize the similarity relations between the individuals from different geographic regions we generated a minimum spanning tree (MST) based on Pearson's correlation coefficients between their SOM-portraits ([Figure 2A](#F2){ref-type="fig"}). For comparison we generated an independent component analysis (ICA) plot which is often applied as similarity presentation in population genetics ([Supplementary Figure S3](#SM1){ref-type="supplementary-material"}). The results reflect the variation of disease-associated alleles across the geographic regions. Interestingly the MST resembles also the distribution of the populations across the geographic regions ranging from Africa at one end to America and Oceania at the other one. A similar MST was recently reported by us using a selection of most variant SNPs instead for disease-associated ones ([@B9]). The disease-associated SNP-genotypes selected here reflect similar genetic drift effects as the most-variant SNPs.

![Variation of disease-associated SNP portraits across geographic regions. **(A)** Mean SNP-portraits of seven geographic regions show systematic changes of their spot patterns. A minimum spanning tree (MST) was calculated using Pearson's correlation coefficient between the SOM portraits of the individuals to visualize the similarity relations between their SNP-patterns. It is mapped on the geographic map to illustrate the relation between the genetic drift and the geographic distribution of the populations. Each circle refers to one individual. Their colors assign the respective geographic region. Armenians (red) form a cluster at the crossroad between African, European, and Asian branches of the MST. **(B)** A zoom-in SOM was calculated using data of selected populations from Middle East, Europe and Armenians for SOM-training to better resolve local similarity relations. The zoom-in MST reveals a relative compact clusters of Armenians bordered by populations from Middle East and Europe, respectively. **(C)** Difference portraits of Armenians with respect to other populations show an increase of non-African genetic contributions with respect to Middle Eastern populations and increased European contributions with respect to Central and South Asian populations.](fgene-10-00394-g002){#F2}

Interestingly, the Armenian individuals accumulate into a homogenous cloud at the crossroad between three branches collecting populations from (sub-Saharan) Africa and Middle-East, from Europe and from Asia, respectively. This localization of the Armenian cluster is in accordance with the previous genetic studies based on the genetic variation data on autosomal and uniparental loci ([@B23]; [@B19]; [@B58]).

A more detailed view using a zoom-in SOM using only populations from the Middle East and Europe further emphasize the intermediate position of the Armenian population in-between the Middle East and Europe ([Figure 2B](#F2){ref-type="fig"}). Difference portraits show that disease-associated allele-landscapes of Armenians are characterized by non-African patterns compared with Middle East populations and by European patterns compared with Central and South Asian populations. The difference in comparison to other European populations is subtler showing also marked similarities in the allelic composition. In summary, SOM-portrayal of disease-associated SNPs reflects and characterizes the distribution of humans across geographical regions. Armenians occupy a central position of their disease-associated genome between Middle Eastern, European, and Central Asian populations in a region of an ancient crossroad of human migration.

Segmenting the SNP Landscape Into Minor-Allelic Spots
-----------------------------------------------------

The majority (about 70%) of minor alleles in the HGDP dataset associated with the diseases studied, which is in accordance with previous observations ([@B29]). We were interested to study clusters of co-localized minor-allelic SNPs that are evident as red, spot-like areas in the SNP-portraits. The spot summary map collects all relevant red spots (clusters of SNPs with minor allele high frequency) to provide an overview of the minor-allelic spot regions observed in the mean SOM portraits of the different geographic regions ([Figure 3A](#F3){ref-type="fig"}). Overall we identified 13 minor-allelic spots labeled by capital letters A--M ([Figure 3A](#F3){ref-type="fig"}). Mean profiles averaged over the allelic codes of all alleles collected in the respective spot reveal the geographic specificity of minor allele prevalence ([Figure 3C](#F3){ref-type="fig"}). We identified seven spots which were unique for a given geographic region and another six (mixed) spots which shared between several regions ([Figure 3D](#F3){ref-type="fig"}). For instance, portraits for Armenians, Europeans, Central South Asians and populations from the Middle East are characterized by red spots located in the right-lower corner, while the portraits from (sub-Saharan) Africa and from East Asia show different spots in the right and left upper corners of the map, respectively. On the other hand, SNP portraits from Oceania and, to a lesser degree, from America are characterized by two or more spot both unique and/or mixed distribution. For example, spot L reflects similar minor allelic SNP profiles of Oceanians, Native Americans and East Asians and partly also Africans while spot I reflects common genetic history of original populations in America and East Asia.

![Characterization of the SNP landscape. **(A)** The spot summary map segments into 13 spots (see labels A--M) enriching minor-alleles in a population/geography specific way. **(B)** The positions of 17 SNPs referring to different genes selected from the top 40 genes having a high number of disease associations ([@B42]) in the SOM are indicated by arrows. Accumulation of these genes in the spot areas is indicated by dashed circles. The profiles of selected SNPs reveal a population-specific enrichment of minor-allelic scores. **(C)** Mean allele profiles of the SNPs collected in each of the spots are shown as barplots. Each of the spots refers to a different profile. **(D)** Part of the spots can be assigned to one geographic region while 'mixed' spots show enrichment of minor alleles in populations from more than one region (see also the mean portraits in [Figure 2A](#F2){ref-type="fig"}).](fgene-10-00394-g003){#F3}

In order to demonstrate how SOM assigns single SNPs into clusters based on their allele frequency profiles, we mapped 40 SNPs from 17 genes with a high number of disease associations taken from [@B42] into the SNP landscape ([Figure 3B](#F3){ref-type="fig"}). The most of the SNPs accumulate in the regions of spots D and E (19.5%) and of spots J and K (34.1%) corresponding to European and East Asian populations, respectively. About 38% of the genes were found in or near spots assigned to minor allele enrichment in other geographic regions such as Africa, Oceania, and America. This unbalanced distribution is presumably due to the population bias in the studied SNPs toward Europe and East Asia. It emphasized the necessity of extending genetic association studies to other populations.

We also evaluated the effect of linkage disequilibrium (LD) on distribution of SNPs in the SOM portraits, using SNPs located on chromosome 1 available in our dataset. SOM algorithm naturally tries to allocate SNPs with correlated profiles in close proximity (or in the same cluster) while SNPs with anti-correlated profiles are positioned in furthest regions of the SNP portrait. Thus SNPs that are in LD will be either located in one cluster (for positively associated alleles) or in two clusters located most distantly on the "SNP portrait" (for negatively associated alleles) ([Supplementary Figure S4](#SM1){ref-type="supplementary-material"}). Furthermore, since the disease-associated SNPs used in our study were already "pre-selected" based on GWAS or functional studies, and since the goal of our study was "portraying the population-level genetic risks" for known associations rather than identifying new ones, we can assume that LD's effect on our findings was minimal.

Thus, the SOM method aggregates disease-associated alleles into clusters associated with one or more regions this way reflecting geographical variability of disease susceptibility coded in MAF.

Associations Between Diseases and Spot-Modules of SNPs and Their Functional Context
-----------------------------------------------------------------------------------

Next, we evaluated disease enrichment in spots compared with their background distribution based on the clustered SNPs using Fisher's exact test. This "background" distribution shows that the largest number of SNPs is associated with complex diseases such as cardiovascular, nervous and respiratory system disorders and carbohydrate metabolism disease ([Supplementary Figures S5](#SM1){ref-type="supplementary-material"}, [S6](#SM1){ref-type="supplementary-material"}).

We detected 11 significant disease associations per spot on the average ([Supplementary Figures S7](#SM1){ref-type="supplementary-material"}--[S19](#SM1){ref-type="supplementary-material"}). The top diseases per spot are presented in [Figure 4A](#F4){ref-type="fig"}. Hereby the same diseases such as carbohydrate metabolism disease (diabetes mellitus), mood disorders, immune system, and neuronal diseases enrich in different spots. These redundantly distributed diseases typically associated with SNPs in different genes as shown in the plots in [Figure 4C](#F4){ref-type="fig"}. They revealed predominantly a one-to-one relation between the SNPs in spots and diseases ([Figure 4B](#F4){ref-type="fig"}). The distribution of genes counts over the spots ([Figure 4C](#F4){ref-type="fig"}) roughly follows an exponential decay law meaning that the number of genes associated with one spot dominates over the number of genes associated with multiple spots.

![Spot-enrichment of disease-associated SNPs. **(A)** Top enriched disease terms in each of the spots (see [Supplementary Figures S7](#SM1){ref-type="supplementary-material"}--[S19](#SM1){ref-type="supplementary-material"} for full lists of enriched diseases and [Supplementary Figures S5](#SM1){ref-type="supplementary-material"}, [S6](#SM1){ref-type="supplementary-material"} for their background distribution). Enrichment *p*-values are obtained using Fishers exact test. **(B)** The circular plots link genes with spot-clusters containing SNPs referring to these genes. Each circular plot shows SNPs which associate with one disease. Different genes which associate with the same disease distribute over different spots. Genes specifically accumulate in the spots in a one-to-one fashion as a rule of thumb. Only a few genes were found in two or more spots according to different SNPs in the same gene (e.g., SH2B3). Examples were shown for three selected disease classes. **(C)** The number--number distributions over the spots follow an exponential decay meaning that the majority of genes associates with a single spot.](fgene-10-00394-g004){#F4}

In order to further assess the difference on the functional context of the genes carrying the SNPs, we performed functional annotation of GO in each spot using over-representation analysis implemented in Webgestalt web-server ([@B55]). The results demonstrate that each spot is characterized by an almost unique set of enriched GO biological process terms ([Figure 5A](#F5){ref-type="fig"}). Similar patterns are observed in the enrichment of GO terms related to molecular function ([Supplementary Figure S20](#SM1){ref-type="supplementary-material"}) and cellular localization ([Figure 5B](#F5){ref-type="fig"}). On the other hand, one finds the same terms \[e.g., related to adhesion, which plays an important role in maintaining the physiological state of various organs ([@B36])\] in different spots. Other GO-terms enriched in the spots included cell migration, cell and organ development and signaling which all appear to be deregulated in various diseases.

![The biological context of the spots is estimated by means of enrichment analysis using the GO terms **(A)** biological process and **(B)** cellular component. Enrichment *p*-values (Fisher's exact test) were visualized as heatmap. One sees that, e.g., GO-terms related to neuronal function are enriched in most of spots but especially in spots showing minor allele preference in Europeans.](fgene-10-00394-g005){#F5}

Our results underpin the complex character of diseases pathophysiology, which involves deregulations in multiple biological pathways and cellular networks ([@B59]) often in a population-specific fashion ([@B46]). In summary, our results demonstrated considerable specificity of the distribution of genes and biological processes associated with the same diseases at the geographic levels.

Genetic-Risk Profiling
----------------------

For the detailed overview, we represented the disease-spot associations as a heatmap in [Figure 6A](#F6){ref-type="fig"}. We compared them with the minor allele score profiles of the spots ([Figure 6B](#F6){ref-type="fig"}) to combine the assignment of diseases with geographic regions.

![Associations of spots with diseases **(A)** and with geographic regions **(B)** are shown as heatmaps. Diseases represented with high numbers of SNPs in the background distribution accumulate in the lower part of the heatmap **(A)**. More rarely-presented diseases frequently associate with one or two spots only **(A)** which, in turn, are assigned to specific regions according to the respective mean allele score **(B)**. SNPs associated with mood disorders are enriched in spots having high MAF in Europeans and East Asians which corresponds to the enrichment of GO-terms related to neuronal functions in [Figure 5](#F5){ref-type="fig"}.](fgene-10-00394-g006){#F6}

The diseases accumulating in the lower part of the heatmap in [Figure 5A](#F5){ref-type="fig"} are the most thoroughly studied ones showing highest overall enrichment in the background distribution (compare with [Supplementary Figure S5](#SM1){ref-type="supplementary-material"}) as well as in spots. According to the minor allele enrichment, these diseases can be considered as the most prevalent ones worldwide. Indeed, the global prevalence of diabetes (carbohydrate metabolism disease) is 8.5% ([@B25]), which makes it one of the most frequent diseases. Mood disorders (bipolar disorder, anxiety, and depression) are considered as the most frequent mental conditions ([@B52]), while immune system cancers (mostly malignant diseases of blood and lymphoid system) also have been reported to have high incidence rate worldwide ([@B16]). Thoracic cancer (including lung cancer) associated SNPs were significantly enriched in three spots (A, E, K) covering all geographic regions.

The diseases in the upper part of the heatmap in [Figure 6A](#F6){ref-type="fig"} are less enriched in the background distribution and thus they refer to moderately prevalent/studied ones. These diseases reveal region specificity of spot enrichment.

For example, vitamin metabolic disorders associated SNPs were enriched in spots A and K showing increased minor allele scores in Africa and East Asia, respectively. Vitamin deficiency in these regions was mostly attributed to economic and political reasons and also to local dietary practices ([@B4]). Our results, however, showed that four SNPs (rs1348864, rs4778359, rs7781309, rs9937918) which associate with vitamin D metabolism ([@B7]; [@B14]) show high MAF in Africa and East Asia suggesting also increased genetic risk. Notably, for these regions, low levels of the vitamin D deficiency marker 25-hydroxyvitamin D in blood were reported ([@B40]; [@B41]).

Likewise, SNPs for bilirubin metabolic disorder accumulate in five spots (A, D, E, F, and K) linked to Africa, Europe, the Middle East, Asia, and Armenia. Interestingly, previous studies clearly implicated SNPs identified in the spots with the serum bilirubin levels in Europeans, Asians, and Africans ([@B27]; [@B11]; [@B13]). Moreover, population-dependent sets of mutations and polymorphisms were shown to be implicated in the development of inherited disorders of bilirubin clearance ([@B35]).

Finally, we found that some diseases are enriched in a single spot. For example, SNPs related to anxiety disorders were significantly enriched in Europe, the Middle East and Armenia (spot D). This result is in line with the large-scale meta-analysis performed by [@B5] indicating significantly reduced risk for anxiety disorders in non-western cultures compared with the western ones.

Overall, the results of population levels genetic risk profiling indicate a bias toward more prevalent diseases with global impact, such as cancers, immune system diseases, and diabetes. This, in turn, results in a larger number of associations, compared with less widespread diseases. We also find that the enrichment of diseases associated SNPs links to the disease prevalence in many cases.

Genetic Risks of Armenians
--------------------------

The analysis of the global SNP-landscape of worldwide populations provided an overview of the geographic distribution of disease-related genetic risk factors. However, it virtually does not resolve finer-granular population-level diseases-associations, especially, for relatively small populations such as Armenians. Our initial analyses reveal patterns of disease-associated alleles that they share with neighboring populations from the Middle East and Europe (e.g., Spots D and E in [Figure 3A](#F3){ref-type="fig"}).

A detailed comparison of SNP portraits showed that Armenians are characterized by different spot patterns compared with that observed for populations from Europe, the Middle East and Central South Asia ([Figure 2C](#F2){ref-type="fig"}).

In order to better resolve differences between these neighboring populations, we performed a so-called zoom-in SOM-analysis ([@B57]) that considered only populations from Europe (French, Sardinian, Russian, North Italians), Middle East (Bedouin, Druze, Palestinians) and Armenia.

It revealed a spot cluster of minor alleles of SNPs which specifically characterize Armenians (spot H in [Figure 7](#F7){ref-type="fig"}). These SNPs associated with immune diseases, diabetes mellitus, skin diseases, and musculoskeletal diseases as the top-four ones. The top SNPs showing highest MAF, the affected genes, associated diseases and their incidence in Armenia ([@B2]) are listed in [Table 1](#T1){ref-type="table"}.

![Zoom-in analysis of selected populations from Europe and Middle East and of Armenians resolve geographic specifics of association between SNPs and disease risks with higher resolution. **(A)** Spot enrichment of diseases and **(B)** of minor allele scores are shown as heatmaps. Notably, spot H collects SNPs which suggest specifically increased disease risks in Armenians. **(C)** Profiles of spot H in the zoom-in and the world-wide SOM indicate specifically increased MAF of the included SNPs for Armenians. Top diseases which associate with spot H are shown as barplot of enrichment *p*-values.](fgene-10-00394-g007){#F7}

###### 

Top disease-risk associated SNPs in Armenians.

  SNP-ID^∗^    Genomic region/GENE SYMBOL   REF/ALT   MAF Armenia   MAF other   P ASSOC   DO_TERM                                    Prevalence per 100000 in Armenia
  ------------ ---------------------------- --------- ------------- ----------- --------- ------------------------------------------ ----------------------------------
  rs2848713    Intergenic                   G/A       0.21          0.1         5.6E-45   Behcet's disease                           NA
  rs2298075    SEC31B                       C/A       0.35          0.2         2E-04     Breast cancer                              66
  rs10166672   Intergenic                   A/G       0.24          0.15        9E-04     Alzheimer's disease                        NA
  rs627834     Intergenic                   A/G       0.25          0.07        3.3E-04   Alzheimer's disease                        NA
  rs10952163   Intergenic                   A/G       0.22          0.08        8.6E-05   Obesity                                    NA
  rs17213431   ANLN                         G/A       0.26          0.1         4.4E-05   Obesity                                    NA
  rs11669309   LOC284395                    C/T       0.21          0.09        9E-04     Hypertension                               5643
  rs4239131    Intergenic                   T/C       0.2           0.09        4.4E-04   Gilles de la Tourette syndrome             NA
  rs4239131    Intergenic                   T/C       0.2           0.09        4.4E-04   Obsessive-compulsive disorder              NA
  rs4239131    Intergenic                   T/C       0.2           0.09        4.4E-04   Attention deficit hyperactivity disorder   NA
  rs7022505    Intergenic                   C/T       0.22          0.12        3.7E-06   Kidney disease                             NA
  rs10237038   FLJ43663                     C/T       0.22          0.11        2.7E-05   Pancreatic cancer                          32
  rs2269706    PPP1R18                      G/A       0.21          0.16        6.3E-06   Rheumatoid arthritis                       865
                                                                                                                                     

∗

SNPs were located in spot H (

Figure 6

) and further sorted according maximum ratio MAF (Armenians)/MAF (others)

.

For example, the incidence of Behcet's disease was reported to be higher in Armenians and other South Caucasus populations compared with Russians ([@B31]). The highest prevalence of this disease has been reported among Turkish (450--500 per 100000), however, the prevalence of 90 per 100000 in ethnic Armenians ([@B39]) is still considerably higher compared to Europeans ([@B32]).

Toutette syndrome SNP is among the disease SNPs associated with Armenians. Systematic studies considering 44 populations have reported that Tourette syndrome is rare among Afro-Americans in the United States and sub-Saharan Africans. Till date, most of the Tourette syndrome cohorts have been described from Western sites and also from China, Japan, and the United Arab Emirates ([@B44]).

Currently no data is also available about the incidence and prevalence rates of Alzheimer's disease in Armenia, however, it is accepted that the actual rates are comparable if not higher compared with worldwide rates ([@B50]; [@B54]). Official statistics is also unavailable for obesity; however, the 2013 report by WHO ([@B56]) indicated that 55.5% of the adult population in Armenia were overweight and 24.0% were obese. Overall our analysis suggests links of population-level enrichment of diseases associated alleles and disease prevalence particularly in Armenians, which however presently lack reliable data about disease prevalence.

Discussion
==========

In this study, we analyzed population and geographic region-wide distributions of disease-associated genetic risk factors using SOM machine learning. This approach generated region and population specific "SNP portraits" visualizing the distribution of disease-predisposing alleles and allowed for direct comparisons and assessment the variation of disease-associated alleles across the geographic regions.

Our results clearly indicate that there region/population-level specifics in the enrichment of disease-associated alleles, which could be linked to the disease prevalence. Moreover, we noticed a significant variation of disease predisposition background across the worldwide populations, in particular, for common diseases, such as diabetes, cancers, cardiovascular, and mental diseases. These observations confirm driving their multifactorial nature and involvement in multiple pathways their pathogenesis. It is worth to note that the low-frequency alleles associated with a disease in one population showed considerably high population levels frequency in another. We also observed a bias in present knowledge toward most prevalent diseases (like cancers, diabetes) as well as toward variants reported in Western World and few Asian and African populations. Future studies are required which focus more on so far understudied diseases and populations.

Further, our results raise the question of how the genetic risk in one population transfers into another one and it emphasizes the need for involving as much as possible populations into clinical genomics initiatives.

As an example of the understudied population, we focused on Armenians. Portraying of disease-related SNPs in Armenians demonstrated similarities with the Middle East, European and Central Asian populations. A more detailed analysis detected SNPs with specifically increased MAFs in Armenians compared with all other populations studied which indicates local disease prevalence in agreement with epidemiological data.

It is worth to notice a few limitations of our analysis. Population-level high MAFs does not necessarily indicate increased disease's susceptibility or prevalence in a particular region. Alternatively, it can be also the result of long periods of "non-exposure" to the disease in a certain population. Next, our study neglected a large number of variations of disease-causing mutations, because they were not included neither in the array data used nor in available disease association catalogs. DNA sequencing will have more resolution in this respect, but there is presently no enough consistent data. Currently, there are several available datasets that contain exome or whole genome sequencing data from various population genetic and disease-specific studies, such as ExAC/gnomAD or 1000 Genomes which will enable studying population diversity based on larger number of samples. We have chosen HGDP for our methodical study because it provides a relative large population diversity which still exceeds that in the other datasets (51 in HGDP vs. 26 in 1000 Genomes, 10 in genomAD, and 17 in ExAC) and because of matched measuring platforms with SNP-data for Armenians. Future studies have to consider population diversity in Caucasus region and the surrounding areas and also ancient samples which become increasingly available for more detailed disease-risk profiling in space and time.

From a methodological point of view, our study demonstrates the power of machine learning and, particularly, of SOM portrayal or analyzing genomic data. This method possesses strong visualization capabilities by providing maps of the SNP-landscapes of the populations under study. They project the highly-multidimensional SNP-patterns strictly into two dimensions in contrast to principal component plots which still are multidimensional. Moreover and most importantly, the method generates a "SNP portrait" for each individual this way enabling the personalized evaluation of its SNP-patterns. These individual portraits can be used to generate mean portraits averaged over selected groups of individuals, e.g., of populations from selected geographic regions which then can be compared to identify common and different SNP patterns. The strong clustering capabilities of SOM deliver groups of SNPs showing similar profiles and application of enrichment techniques provide their functional and disease context. The method needs further development for applications to genomic data, for example, to include other genetic defects and to integrate and to visualize additional phenotypic information.

Overall, our novel approach extends the toolset employed of association and population genetic studies. The strength of SOM portrayal used here can be seen in the possibility of disentangling entire genetic variation landscape into functional clusters, which subsequently can be assigned to various features of the groups studied. This includes stratification of populations and identification of diseases associated variants.

Conclusion
==========

Our results clearly indicate that there is a great scope for further research in this area. There is a strong need to include non-Western populations in future studies that are clinically, geographically, and ethnically well-characterized.
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